Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 9/26/2020 2:00:02 PM
Platelet profiles could inform care for #bleedingdisorders, #breastcancer, #cardiovasculardisease and more:…
BCH Innovation News @BCH_Innovation 9/25/2020 8:00:00 PM
New research shows common #blood test could help doctors predict mortality risk in #COVID19 patients:…
BCH Innovation News @BCH_Innovation 9/25/2020 7:00:02 PM
Many children with #immunethrombocytopenia don’t have significant bleeding, even when #platelets are low. Researche…
BCH Innovation News @BCH_Innovation 9/25/2020 4:00:01 PM
Could platelet profiling predict bleeding risk in immune #thrombocytopenia? Ben Spurgeon, @alfrelinger, Rachael Gra…
BCH Innovation News @BCH_Innovation 9/24/2020 7:00:01 PM
New anti-cancer #antibody drug tailored to personal #genomics to start clinical trials: via @GeneticLiteracy
BCH Innovation News @BCH_Innovation 9/24/2020 2:00:02 PM
New “liquid biopsy” #blood tests are designed to quickly find genetic material shed, giving doctors more insight on…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer

Powered by GlobalLink OneLink SoftwarePowered By OneLink